Shilpa Medicare Limited: Pemrydi Rtu(pemetrexed Injection), 500 Mg/50 Ml (10 Mg/ml), Single-dose Vial

PEMRYDI RTU Recall Summary Shilpa Medicare is recalling PEMRYDI RTU (pemetrexed injection) 500 mg vials distributed nationwide because some vials contain green to dark green discoloration in the solution. The affected product was manufactured by Zydus Lifesciences and distributed by Amneal Pharmaceuticals. This recall affects patients who received this cancer medication across all U.S. states and Washington, D.C.

Recalling firm
Shilpa Medicare Limited
Product
PEMRYDI RTU(pemetrexed injection), 500 mg/50 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridgewater, NY 08807. NDC: 70121-2461-1
Reason
Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
Classification
Class II
Category
drug recall
Country
United States
Agency
U.S. Food and Drug Administration
Recall date
2026-07-29
Status
Ongoing
Areas affected
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
Distribution
Nationwide in the USA.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/8955c2ef-8b5d-4c07-9c69-c36338c3e746